Cheiro-Oral Syndrome: A Clinical Analysis and Review of Literature by Chen, Wei Hsi
Yonsei Med J   http://www.eymj.org    Volume 50   Number 6   December 2009 777
In 1914, Sitting
1 reported three patients presenting with unilateral sensory
impairment which was restricted at their perioral area and homolateral distal
finger(s)/hand. Their responsible lesions, namely encephalitis, gumma, and
vascular malformation, were found at their contralateral postcentral gyrus on
autopsy for a period of time after onset. Later, this peculiar sensory disorder was
also found in thalamic stroke.
2,3 This characteristic unilateral sensory disorder was
soon coined as cheiro-oral syndrome (COS). At that moment, COS was considered
to proffer two contributions in clinical medicine, including a neuroanatomic
localization at cortex or thalamus and a benign neurological course. 
Following the advert of COS in Europe, an accumulation of case series of COS
has subsequently been reported in European countries other from German and
France, North America, Japan, Korea
4 and Taiwan.
5 In contrast to previous sugges-
tion that COS provides a localizing value,
6 current knowledge has already realized
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Purpose: After a century, cheiro-oral syndrome (COS) was harangued and emphasized for its localizing value and
benign course in recent two decades. However, an expanding body of case series challenged when COS may arise
from an involvement of ascending sensory pathways between cortex and pons and terminate into poor outcome
occasionally. Materials and Methods: To analyze the location, underlying etiologies and prognosis in 76 patients
presented with COS collected between 1989 and 2007. Results: Four types of COS were categorized, namely
unilateral (71.1%), typically bilateral (14.5%), atypically bilateral (7.9%) and crossed COS (6.5%). The most
common site of COS occurrence was at pons (27.6%), following by thalamus (21.1%) and cortex (15.8%). Stroke
with small infarctions or hemorrhage was the leading cause. Paroxysmal paresthesia was predicted for cortical
involvement and bilateral paresthesia for pontine involvement, whereas crossed paresthesia for medullary
involvement. However, the majority of lesions cannot be localized by clinical symptoms alone, and were
demonstrated only by neuroimaging. Deterioration was ensued in 12% of patients, whose lesions were large
cortical infarction, medullary infarction, and bilateral subdural hemorrhage. Conclusion: COS arises from varied
sites between medulla and cortex, and is usually caused by small stroke lesion. Neurological deterioration occurs in
12% of patients and relates to large vessel occlusion, medullary involvement or cortical stroke. Since the location
and deterioration of COS cannot be predicted by clinical symptoms alone, COS should be considered an emergent
condition for aggressive investigation until fatal cause is substantially excluded.
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INTRODUCTIONthat COS can arise from an involvement of the spino-
thalamocortical and trigeminothalamocortical tract between
pons and sensory cortex. A few corresponding etiologies
are also found. In recent publications, there are three main
streams of thought concerning COS: an association with
uncommon intracranial cause,
7,8 concomitant uncommon
neurological deficits,
9,10 and an increasing number of
variants.
11-13 This trend adumbrates COS merely a clinical
presentation without diagnostic or prognostic value. In this
study, the neuroanatomy, underlying cause and clinical
course were analyzed in 76 patients presenting with COS.
In contrast to recent suggestion that COS displays a
poverty of diagnostic and prognostic value, COS was
actually found to be an early warning sign for neurological
exacerbation obligatory for aggressive investigation herein. 
A prospective study has been carried out to analyze the
localization, pathogenesis and prognosis of COS since
1989 (from 1989 to 2000 at Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan, and from 2001 to 2007 at
Chang Gung Memorial Hospital-Kaohsiung Medical
Center, Kaohsiung, Taiwan). In this database, COS was
strictly defined as a sensory impairment confined to the
perioral area and the ipsilateral finger(s)/hand, without a
detectable abnormality in mental, memory, motor or cere-
bellar function. COS patients were also excluded when
COS was an ictus in migraine or due to intoxication from
marine toxin or other cause. However, a mild change of
tendon reflex or muscle tonicity without a decrease of
muscle strength, an association with a focal seizure or
movement disorder, or a neurological deficit probably due
to previous event was not contraindicated. Each patient
received detailed medical history evaluation, neurological
examination, cranial computerized tomography or magnetic
resonance image, and somatosensory evolved potential to
localize their pathological location. If necessary, further
appropriate tests would be performed and their procedures
had been mentioned in previous reports.
5,14-19 
A corresponding lesion was defined as a lesion which
was detected under neuroimaging study, and was time-
and neuroanatomic-compatible with concomitant neurolo-
gical manifestation. Accordingly, a T2-weighted or fluid
attenuated inversion recovery (FLAIR)-weighted intensity
situated within the ascending sensory pathway could not
be considered a corresponding lesion if there was no
parallel change in diffusion weighted image (DWI) or
apparent diffusion coefficient (ADC)-weighted image, and
in T1-weighted image if hemorrhage was considered.
Patient was considered to have no corresponding lesion
when there was no lesion found, lesion not compatible
with concomitant neurological manifestation, or only T2-
weighted or FLAIR-weighted hyperintense lesion without
parallel change in DWI, ADC or T1-weighted image. 
In case of brainstem hemorrhage which extended beyond
one or more neuroanatomic landmarks (midbrain, pons,
medulla oblongata), the location was selected for the site
where the hematoma volume was the biggest. The hema-
toma or infarction at brainstem was considered large when
the area of infarction or hematoma was over one-fourth
area of brainstem at the same level. Otherwise, it was small. 
Categorical variables were expressed as number and
percentage. Chi-Square test and Fisher exact test were used
for statistical analysis. A probability less than 0.05 was
accepted as significance. 
Between 1989 and 2007, there were 76 patients presented
with COS enrolled. Some of them had been reported in
previous publications.
5,14-19 They were 49 men and 27
women. The age ranged from 41 to 74 years. 
Classification
Basing on the distribution of sensory impairments, four
types of COS were categorized. Type I COS was sensory
impairment confined to perioral area and homolateral
finger(s)/hand in unilaterality. Type II COS was sensory
impairment confined to perioral area and finger(s)/hand in
bilaterality. Type III COS was sensory impairment confined
to perioral area and finger(s)/hand in that one was involved
in bilaterality whereas another one in unilaterality. It was
an incomplete and atypical form of type II COS. Type IV
COS was sensory impairment confined to perioral area and
opposite finger(s)/hand, or crossed COS. Finally, type I
included 54 patients (71.1%), type II 11 patients (14.5%),
type III 6 patients (7.9%), and type IV 5 patients (6.5%).
Neurological manifestations and associated symptoms
All patients presented an abrupt onset of paresthesia con-
fined to perioral area and finger(s)/hand initially without
conscious change. Their paresthesia was usually described
as numb or tingling, and also piercing, thickening, thinning,
burning, spicy, coldness, ice, or crawling. In three patients,
subjective paresthesia occurred at fingers whereas hypes-
thesia to pinprick pain and cotton fine touch was only
detected at perioral area on examination. Intermittent focal
motor convulsion was present in 1 patient with cortical
meningioma and another one with arteriovenous malfor-
mation after onset. 
The paresthesia was constant in 70 patients whereas
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paroxysmal in another 6 patients; namely, 3 type I patients
whose etiology was cortical arteriovenous malformation or
meningioma, 1 type I patient with subdural hemorrhage,
and 2 type 1 patients with pontine infarction in whom their
sensorum exacerbated in parallel to an increase of blood
pressure.
17 Paroxysmal paresthesia was more frequent in
patients with cortical involvement (4 out of 12; 33.4%)
than subcortical involvement (2 out of 70; 2.9%) in this
series. Accordingly, a paroxysmal COS would predict for
cortical involvement (Fisher’s exact test, p = 0.0038).
A variable magnitude of exterioceptive (pinprick pain or
cotton fine touch) or proprioceptive (positional joint sensa-
tion or vibratory sense) hypesthesia, ranging from 20% to
70% subjectively, was detected at perioral area or finger(s)/
hand in most patients. No patient showed anesthesia to
sensory stimulation. In practice, the magnitude of proprio-
ceptive hypesthesia was usually mild. Cortical type-sensory
impairment (astereognosis, barognosis, or graphesthesia)
was detected in 6 patients (50.0%) with cortical involve-
ment whereas 3 patients (18.8%) with thalamic involve-
ment. Objective hypesthesia to pinprick pain, cotton fine
touch, positional joint sensation and vibratory was detected
in 6 (50.0%), 6 (50.0%), 4 (33.4%), and 4 (33.4%) out of 12
patients with cortical involvement; 12 (75.0%), 14 (87.5%),
4 (25.0%), and 4 (25.0%) out of 16 patients with thalamic
involvement; and 15 (71.4%), 16 (76.2%), 3 (14.3%), and 4
(19.1%) out of 21 patients with pontine involvement,
respectively. Cotton fine touch was the most common sen-
sation involved. There was no difference in the frequency
of exterioceptive or proprioceptive hypesthesia among
cortical, thalamic and pontine involvement. However, a
presence of cortical type-sensory impairment predicted for
cortical involvement and thalamic involvement less. In
addition, a crossed sensory impairment exclusively indicat-
ed medullary involvement.
Associated symptoms were absent in 27 (35.5%), but
present in 49 (64.5%) patients. The most frequent symptom
was dizziness in 41 patients. Other dizziness-minus
symptoms included facial flushing/hotness in 11, vertigo in
8, palpitation in 7, headache in 6, fatigue in 6, unsteadiness
in 5, nausea in 3, blurred vision in 3, chest tightness in 3,
tinnitus in 2, near-syncope feeling in 1, abdominal hyperac-
tive feeling in 1, strange feeling to environment in 1, tooth-
falling feeling in 1, and hiccough in 1 patient (Table 1). In
these 49 patients, isolated dizziness was present in 17
patients, isolated dizziness-minus symptoms in 8 patients,
and both dizziness and dizziness-minus symptoms in 24
patients. Dizziness and vertigo persisted for more than one
day in some patients, however, all other associated symp-
toms subsided within 24 hours after onset.
Associated medical disorders
Hypertension was present in 53 patients and was the most
common associated medical comorbidity. Diabetes mellitus,
Sjogren syndrome, and recent traumatic head injury were
found in 9, 1 and 1 patient, respectively. In 18 patients, there
was no associated medical comorbidity known before, but
arteriovenous malformation, meningioma and acute myelo-
genous leukemia were found in 5 patients later after
investigation. 
Locations of lesions 
Single lesion was found in 54 patients (71.1%), multiple
lesions in 1 patient (1.32%) and no definite lesion in 21
patients (27.6%) (Table 2). The most common site of
single lesion was pons (27.6%), followed by thalamus
Table 1. The Neurological Manifestations and Associated 
Symptoms in 76 Cheiro-Oral Syndrome Patients
Associated symptoms  Cases number (%)
Absence 27  (35.5)
Presence 49  (64.5)
Dizziness 41 (83.7)
Facial flushing / hottness 11 (22.5)
Vertigo 8 (16.3)
Palpitation 7 (14.3)
Fatigue 6  (12.2)
Headache* 6 (12.2)
Unsteadiness 5 (10.2)
Nausea 3 (6.12)
Blurred vision 3 (6.12)
Chest tightness 3 (6.12)
Tinnitus 2 (4.08)
Near-syncope feeling 1 (2.05)
Abdominal hyperactive feeling 1 (2.05)
Strange feeling 1 (2.05)
Tooth-falling feeling 1 (2.05)
Hiccough 1 (2.05)
*New headache not occurred before.
Table 2. The Locations of Corresponding Lesions in 76 
Cheiro-Oral Syndrome Patients
Locations  Cases number (%)
Cortex 12  (15.8)
Corona radiata  1 (1.32)
Thalamus 16  (21.1)
Midbrain 0  (0.00)
Pons 21  (27.6)
Medulla oblongata 4 (5.26)
Multiple sites 1 (1.32)
Unknown 21 (27.6)Wei Hsi Chen
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(21.1%), cortex (15.8%), and medullary oblongata (5.26%).
No patient had midbrain involvement. In 11 of those 21
patients without definite intracranial lesions, previous
multiple infarctions, hemorrhage or demyelination were
disclosed. In another 6 patients, a variable range of cervical
spondylosis was found. In another 4 patients, there was no
structural abnormality disclosed. 
In the 54 patients in whom single lesion was identified,
type II and III COS predicted for pontine involvement
(Chi-Square test, F = 13.7, p < 0.001) whereas type IV
COS for medullary involvement (Table 3). 
Corresponding etiologies
Stroke was identified in 50 patients (65.8%) and small
infarction was the leading cause in them (34 out of 50
patients; 68.0%). Small infarction and small hemorrhage
were exclusively found at thalamus or pons, except one
patient who had cortical infarction presenting with type I
COS. Tumor and vascular malformation were found in 4
patients and they were exclusively located at cortex (Table
4).
5,18 Multiple sites of infarction were found in 1 patient. In
one Sjogren syndrome patient, her type II COS was ensued
by painful polyneuropathy which was reversed by plasma-
pheresis. Her nerve conduction velocity study showed
sensory axonopathy but magnetic resonance image did not
reveal consistent abnormality. Acute myelogenous leuke-
mia with subdural hemorrhage was found in an another
type I patient after extensive investigation.
18
In regard to stroke patients, detailed survey for stroke
risk factor was performed. In the 3 patients with large
cortical infarction, atherothrombosis was considered as
remarkable atherosclerotic stenosis (≥ 50% stenosis of
luminal area) of intracranial large artery was observed. In
another one patient with small cortical infarction, athero-
sclerosis of middle cerebral artery branch was seen. Her
cardiac function was normal. In those 24 patients with
small infarctions at corona radiata, thalamus or pons,
remarkable atherosclerosis of intracranial or extracranial
arteries was disclosed in 6 of them, whereas minimal to
mild atherosclerosis (≥ 50% stenosis of luminal area) was
common. Old myocardial ischemia was found in 12 patients
and atrial fibrillation in another 2 patients; they also had
had hypertension or diabetes mellitus. There was no patient
having dissecting disease or other nonatherosclerotic
vasculopathy.
Clinical course
There were 9 patients who experienced a deterioration of
neurological function ranging from 3 hours to 1 month
after onset (Table 5).
15,16,18,19 Three patients had medullary
involvement with crossed COS,
19 3 patients had subdural
hemorrhage,
15,18 2 patients had large cortical infarction,
18
Table 3.The Localizing Value in COS Subclasses with Single Lesion
Location / Type
Type I COS Type II COS Type III COS Type IV COS
(n = 54) (n = 11) (n = 6) (n = 5)
Cortex 11 1
Corona radiata  1
Midbrain 0
Thalamus 15 1
Pons 10 6 5
Medulla oblongata 0 4
Multiple sites  1
Unknown 16 3 1 1
COS, cheiro-oral syndrome.
Table 4.The Corresponding Single Etiology in 55 Cheiro-Oral Syndrome Patients 
Etiology / Location  Cortex
Corona 
Thalamus Pons
Medulla Total 
radiata oblongata numbers
Large infarction 3 0 0 0 0 3
Small infarction 1 1 10 13 4 29
Large hemorrhage  4 0 0 3 0 7
Small hemorrhage  0 0 6 5 0 11
Tumor* 2 0 0 0 0 2
Vascular malformation
� 20 00 0 2
*Tumor was meningioma in this series.
�Vascular malformation was arteriovenous malformation in this series.and one patient had large pontine hemorrhage.
16 Surgical
removal of hematoma was done in 2 subdural hemorrhage
patients and decompressive craniotectomy in 1 large cortical
infarction patient. Conservation treatment was performed
Cheiro-Oral Syndrome
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Table 5.Detailed Descriptions of 9 Cheiro-Oral Syndrome Patients with Neurological Deterioration 
Gender Etiology and
Initial manifestations
Interval to Deteriorated
Measures Outcome
Age location  deterioration  manifestations   
Male Left medullary Sudden onset of rotatory 6 hrs Vomiting, left Horner’s Conservative Moderate
53 yrs infarction  vertigo, facial flushing, after onset syndrome, ataxic gait, treatment ataxia
(Ref. 19) throbbing headache,  paresthesia of left arm
tingling sensation at left  and bilateral faces
mouth corner and right 
thumb / forefinger
Female  Left medullary Floating sensation, 3 hrs and Rotatory vertigo, Conservative Mild ataxia
41 yrs infarction nausea, palpitation, 20 mins vomiting, left Horner’s treatment
(Ref. 19) unsteadiness, tingling  after onset syndrome, left
sensation at left mouth  hyperhydrosis, choking,
corner, upper and lower  tongue weakness,
lip, and the first three  paresthesia over
fingers of right hand bilateral faces and right 
hemibody
Male  Right medullary Dizziness, fatigue, 72 hrs Right Horner’s Conservative Mild ataxia
50 yrs infarction piercing pain at right after onset syndrome, rotatory treatment
(Ref. 19) mouth angle and left  vertigo, vomiting,
thumb hyperhidrosis
Female  Pontine large Dizziness, tingling pain 3.5 hrs Right hemiplegia, Respiratory Moderate 
61 yrs hemorrhage at bilateral mouth angle after onset respiratory failure support and ataxia, 
(Ref. 16) and  conservative memory
treatment impairment
Male  Bilateral  Tingling pain at bilateral 1 month Right hemiplegia, hematoma Moderate right
74 yrs subdural mouth angle and after onset aphasia removal hemiparesis,
(Ref. 15) hemorrhage aphasia
Female  Bilateral Dizziness, tingling pain 6 hrs Obtundation, left hematoma Mild left
55 yrs subdural at bilateral mouth angle after onset hemiparesis removal  hemiparesis,
(Ref. 18) hemorrhage and thumbs apraxia
Female  Bilateral Dizziness, palpitation, 2 wks Headache, vomiting, hematoma Moderate right
61 yrs subdural straight feeling, after onset obtundation, removal hemiparesis,
(Ref. 18) hemorrhage Numbness at bilateral  right hemiparesis Broca’s
mouth angle and hands dysphasia
Male Left cortical Thick and numb sensation 2 days Dizziness, right Conservative Moderate right
65 yrs large infarction at bilateral mouth after onset hemiplegia, aphasia treatment hemiparesis,
(Ref. 18) angle and hands Broca’s 
dysphasia
Female  Left cortical Palpitation, heavy and 4 days Headache, dizziness, Decompressive Moderate right 
46 yrs large infarction tingling sensation after onset right hemiplegia, craniotectomy hemiparesis,
(Ref. 18) at bilateral mouth angle  aphasic stuttering stuttering
and handsin another 5 patients.
In another 67 patients who did not experience neuro-
logical deterioration, there was no specific measure other
from cardiovascular risk factor control and stroke secondary
prevention in patients with hemorrhage or infarction. In the
Sjogren syndrome patient, plasmapheresis was done. 
Prognosis
A favorable recovery of COS was ensued in 55 patients
within 6 months after onset. Mild to moderate post-stroke
central pain occurred in 12 patients and was abolished or
attenuated by clonidine, amitriptyline or gabapentin. In
those 9 patients with deterioration, mild ataxia was comp-
licated in 2 of them, but moderate to severe functional
disability was terminated in another 7 patients (Table 5). 
Summary of findings
Besides three clusters of neurological manifestations and
localization, (paroxysmal paresthesia and cortical invol-
vement, typically/atypically bilateral COS and pontine
involvement, and crossed COS and medullary involve-
ment), the predictive weight of neurological manifestation,
associated symptoms, locations of lesions, and underlying
etiologies for prognosis was analyzed. 
Two positive predictors are finally identified, namely
crossed COS and cortical involvement. First, there were 5
crossed or type IV COS patients and 3 of them (60%)
deteriorated soon after onset. Crossed COS highly predict-
ed for deterioration (Fisher exact test, p = 0.007). The odd
ratio, sensitivity, and specificity were 16.25, 60.0%, and
90.1%, respectively. Second, deterioration occurred in 5
out of 12 patients (41.7%) with cortical involvement
whereas 4 out of 64 patients (6.25%) with subcortical in-
volvement. Obviously, cortical involvement also predicted
for deterioration (Fisher exact test, p = 0.008). The odd
ratio, sensitivity, and specificity were 10.7, 41.7%, and
93.8%, respectively. 
Dizziness and dizziness-minus symptoms were exper-
ienced in 49 patients and 7 of them terminated into deterio-
ration, whereas they were not experienced in another 27
patients in whom 2 of them suffered further deterioration.
A presence of dizziness or dizziness-minus symptom did
not predict for deterioration (Fisher exact test, p = 0.62).
The odd ratio was 2.08. 
Although cortical-type sensory impairment and paroxysm
gave a high specificity for predicting cortical involvement,
however, the sensitivity was low. In addition, crossed COS
and cortical COS constituted only 5% and 16% of all cases
of COS, respectively. Therefore, the majority of COS can-
not be predicted, based simply on clinical history, neuro-
logical manifestation and associated symptom. Therefore,
it is reasonable and urgent to schedule indispensable
procedure, especially neuroimaging study, for COS patients. 
In this series, traditional or type I COS, that is character-
ized by an involvement of perioral area and homolateral
finger(s)/hand,
1,20 does not have localizing value. Rather,
the manner of paresthesia and atypical forms of COS show
neuroanatomic correlation. Paroxysmal paresthesia pre-
dicted for cortical involvement. Simultaneously, type II /III
COS predicts for pontine involvement whereas type IV
COS for medullary involvement. COS also cannot predict
for corresponding etiology. Therefore, except for crossed
pattern
19 or bilaterality of sensory deficits,
21 COS is not an
ideal localizing or etiological marker. 
A deterioration of neurological condition was present in
12% of COS patients. Neurological deterioration has sub-
sequently been mentioned in COS patients before.
15,16,18,19,22,23
Therefore, COS can be a warning marker to alarm for a
high possibility of grave deterioration when it presents in
crossed pattern or arises from cortical involvement as
found in this series. Crossed COS indicates an involve-
ment of medulla oblongata and is an incomplete variant of
Wallenberg’s syndrome,
19 in that infarction is due to an
occlusion of vertebral artery and usually carries a high risk
of deterioration and mortality.
24-26 Cortical involvement
usually results from a large lesion.
18 These two positive
predictors, therefore, are expected to increase the risk of
deterioration in COS. However, the sensitivity of these
predictors ranges from 41% to 60% only. Since deterio-
ration can be prevented in some patients,
18 COS should be
considered an emergent condition obligatory for aggres-
sive investigation until underlying cause is known. 
In the present study, 3 patients should be emphasized
because of a diagnostic trap and medicolegal risk in COS.
Sjogren syndrome was in one patient. Her cheiro-oral
paresthesia peaked rapidly and persisted for one week until
pedal painful paresthesia developed simulating cheiro-oral-
pedal syndrome. Since there was no consistent finding in
head neuroimaging, a symmetric distribution of cheiro-
oral-pedal paresthesia favored polyneuritis for her COS.
Her paresthesia was markedly attenuated after plasmap-
heresis. In another two type I COS patients, one who had
had subdural hemorrhage was finally found to have acute
myelogenous leukemia.
18 Another one who also had had
subdural hemorrhage after traumatic minor head injury
deteriorated one month later.
15,18 These experiences indicate
COS not as a simple benign neurological manifestation,
therefore, should carefully be surveyed. 
In conclusion, in contrast to previous concept and recent
publications, COS is eventually a warning marker predict-
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ing for neurological deterioration. Clinically, a rapid neuro-
imaging study to exclude large infarction/hemorrhage or
medullary involvement is necessary. 
1. Sitting O. Klinische Beitrage zur Lehre von der Lokalisation der
sensiblen Rindenzentren [Ger]. Prager Med Wochenschr 1914;
45:548-50.
2. Strauss H. Über Sensibiliätsstörungen an Hand und Gesicht,
Geschmacksstörungen und ihre lokalisatorische Bedeutung [Ger].
Monatsschr Psychiat Neurol 1925;58:265-76.
3. Garcin R, Lapresle J. [2d personal observation of a sensory
syndrome of the thalamic type with cheiro-oral topography caused
by localized lesion of the thalamus.] Rev Neurol (Paris) 1960;
103:474-81.
4. Kim JS. Restricted acral sensory syndrome following minor
stroke. Further observation with special reference to differential
severity of symptoms among individual digits. Stroke 1994;25:
2497-502.
5. Ngai WK, Chang YY, Liu JS, Chen SS. Cheiro-oral syndrome:
identification of the lesion sites and a proposal for its clinical
classification. Gaoxiong Yi Xue Ke Xue Za Zhi 1991;7:536-41.
6. Ten Holter J, Tijssen C. Cheiro-oral syndrome: does it have a
specific localizing value? Eur Neurol 1988;28:326-30.
7. Nakamura M, Mizuguchi M, Momoi MY, Chou H, Masuzawa T.
Transient cheiro-oral syndrome due to a ruptured intracranial
dermoid cyst. Brain Dev 2001;23:261-3.
8. Hasegawa Y, Okada H, Okamoto S. [Neuro-Behçet disease with
bilateral cheiro-oral syndrome following simultaneous multiple
brain hemorrhage.] Rinsho Shinkeigaku 1991;31:754-9. 
9. Kim JS. Cheiro-oral syndrome and vivid recollection of past in
thalamic infarction. Eur Neurol 1997;37:253-4. 
10. Mochizuki A, Eto H, Takasu M, Utsunomiya K, Schoji S.
Cheiro-oral syndrome with internuclear ophthalmoplegia and
cerebellar ataxia following midbrain infarction. Eur Neurol 1994;
34:286-7. 
11. Yasuda Y, Morita T, Okada T, Seko S, Akiguchi I, Kimura J.
Cheiro-oral-pedal syndrome. Eur Neurol 1992;32:106-8.
12. Matsumoto S, Kaku S, Yamasaki M, Imai T, Nabatame H,
Kameyama M. Cheiro-oral syndrome with bilateral oral involve-
ment: a study of pontine lesions by high-resolution magnetic
resonance imaging. J Neurol Neurosurg Psychiatry 1989;52:792-4.
13. Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K, Shiojima T. Oral
syndrome: an incomplete form of cheiro-oral syndrome? Int J
Neurosci 1991;58:271-3.
14. Chang YY, Chen WH, Liu JS, Chen SS, Wu HS. Unilateral
cheiro-oral syndrome in a patient with bilateral subdural hema-
tomas. J Formos Med Assoc 1994;93:727-9.
15. Chen WH, Chang YY, Yin HL, Liu JS. Bilateral cheiro-oral
syndrome and traumatic subdural hematoma. J Trauma 1995;
38:826-7.
16. Chen WH, Lan MY, Chang YY, Liu JS, Chou MS, Chen SS.
Bilateral cheiro-oral syndrome. Clin Neurol Neurosurg 1997;99:
239-43.
17. Chen WH, Tseng YL, Lui CC, Liu JS. Episodic pain syndrome
restricted cheiro-oral region associated with pontine lesion. Brain
Inj 2005;19:949-53.
18. Chen WH, Lan MY, Chang YY, Lui CC, Chen SS, Liu JS.
Cortical cheiro-oral syndrome: a revisit of clinical significance
and pathogenesis. Clin Neurol Neurosurg 2006;108:446-50.
19. Chen WH, Li TH, Chen TH, Lin HS, Hsu MC, Chen SS, et al.
Crossed cheiro-oral syndrome. Clin Neurol Neurosurg 2008;110:
1008-11.
20. Fujisawa A, Imaizumi M, Nukada T. [Clinical study of cheiro-
oral syndrome (author’s transl).] Rinsho Shinkeigaku 1979;
19:17-21. 
21. Yasuda Y, Watanabe T, Tanaka H, Ogura A. Localizing value of
bilateral cheiro-oral sensory impairment. Intern Med 1998;37:
982-5.
22. Hashiguchi K, Igata A. [A case of primary pontine hemorrhage
with cheiro-oral syndrome (palm-oral sensory disturbance).]
Shinkei Naika 1976;5:79-80.
23. Ide M, Yamamoto M, Jimbo M, Enomoto N. [Cheiro-oral synd-
rome with pontine infarct--report of a case.] No To Shinkei 1985;
37:181-6.
24. Kim JS, Lee JH, Lee MC. Patterns of sensory dysfunction in
lateral medullary infarction Clinical-MRI correlation. Neurology
1997;49:1557-63.
25. Kumral E, Afsar N, Kirbas D, Balkir K, Ozdemirkiran T.
Spectrum of medial medullary infarction: clinical and magnetic
resonance imaging findings. J Neurol 2002;249:85-93.
26. Norrving B, Cronqvist S. Lateral medullary infarction: prognosis
in an unselected series. Neurology 1991;41:244-8.
REFERENCES